Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nicol

Showing results (321-330 of 350) with videos related to

Pageof 35
Sort By:
Ulusal Travma Ve Acil Cerrahi Dergisi = Turkish Journal of Trauma & Emergency Surgery : TJTES|November 12, 2013
Management of penetrating injuries of the upper extremitiesOscar J F Van Waes, Pradeep H Navsaria, Renske C M Verschuren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urotheliumChristopher J Sweeney, Bruce J Roth, Fairooz F Kabbinavar, et al.
Investigational New Drugs|December 2, 2010
Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancerStefan Madajewicz, David M Waterhouse, Paul S Ritch, et al.
Nucleic Acids Research|September 14, 2021
Theoretical basis for stabilizing messenger RNA through secondary structure designHannah K Wayment-Steele, Do Soon Kim, Christian A Choe, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
Theoretical basis for stabilizing messenger RNA through secondary structure designHannah K Wayment-Steele, Do Soon Kim, Christian A Choe, et al.
Journal of Clinical Microbiology|February 14, 2014
Molecular epidemiology of merkel cell polyomavirus: evidence for geographically related variant genotypesClaire Martel-Jantin, Claudia Filippone, Patricia Tortevoye, et al.
Scientific Reports|February 22, 2020
Antibacterial effects of low-temperature plasma generated by atmospheric-pressure plasma jet are mediated by reactive oxygen speciesMcKayla J Nicol, Timothy R Brubaker, Brian J Honish, et al.
Poultry Science|December 24, 2010
Hen welfare in different housing systemsD C Lay, R M Fulton, P Y Hester, et al.
Medicine and Science in Sports and Exercise|August 3, 2023
Safety, Feasibility, and Acceptability of a Multisite Individualized Exercise Intervention for People with Multiple MyelomaJennifer L Nicol, Brent J Cunningham, Carmel Woodrow, et al.
Plos One|March 27, 2015
Identification of the neutralizing epitopes of Merkel cell polyomavirus major capsid protein within the BC and EF surface loopsMaxime J J Fleury, Jérôme T J Nicol, Mahtab Samimi, et al.
Pageof 35

Showing results (321-330 of 350) with videos related to

Sort By:
Pageof 35
Ulusal Travma Ve Acil Cerrahi Dergisi = Turkish Journal of Trauma & Emergency Surgery : TJTES|November 12, 2013
Management of penetrating injuries of the upper extremitiesOscar J F Van Waes, Pradeep H Navsaria, Renske C M Verschuren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urotheliumChristopher J Sweeney, Bruce J Roth, Fairooz F Kabbinavar, et al.
Investigational New Drugs|December 2, 2010
Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancerStefan Madajewicz, David M Waterhouse, Paul S Ritch, et al.
Nucleic Acids Research|September 14, 2021
Theoretical basis for stabilizing messenger RNA through secondary structure designHannah K Wayment-Steele, Do Soon Kim, Christian A Choe, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
Theoretical basis for stabilizing messenger RNA through secondary structure designHannah K Wayment-Steele, Do Soon Kim, Christian A Choe, et al.
Journal of Clinical Microbiology|February 14, 2014
Molecular epidemiology of merkel cell polyomavirus: evidence for geographically related variant genotypesClaire Martel-Jantin, Claudia Filippone, Patricia Tortevoye, et al.
Scientific Reports|February 22, 2020
Antibacterial effects of low-temperature plasma generated by atmospheric-pressure plasma jet are mediated by reactive oxygen speciesMcKayla J Nicol, Timothy R Brubaker, Brian J Honish, et al.
Poultry Science|December 24, 2010
Hen welfare in different housing systemsD C Lay, R M Fulton, P Y Hester, et al.
Medicine and Science in Sports and Exercise|August 3, 2023
Safety, Feasibility, and Acceptability of a Multisite Individualized Exercise Intervention for People with Multiple MyelomaJennifer L Nicol, Brent J Cunningham, Carmel Woodrow, et al.
Plos One|March 27, 2015
Identification of the neutralizing epitopes of Merkel cell polyomavirus major capsid protein within the BC and EF surface loopsMaxime J J Fleury, Jérôme T J Nicol, Mahtab Samimi, et al.
Pageof 35